Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Concord Medical Services ( (CCM) ) has provided an update.
Concord Medical Services Holdings Limited announced changes in the controlling shareholders of its subsidiary, Concord Healthcare Group Co., Ltd., which is listed on the Hong Kong Stock Exchange. This announcement follows the previous listing of Concord Healthcare’s H shares on the HKSE on January 9, 2024, and may impact the company’s market positioning and stakeholder interests.
Spark’s Take on CCM Stock
According to Spark, TipRanks’ AI Analyst, CCM is a Underperform.
The overall stock score for Concord Medical Services is significantly impacted by its poor financial performance, characterized by declining revenues, high leverage, and negative cash flows. Technical analysis indicates bearish momentum, and valuation metrics are unfavorable, with a negative P/E ratio and no dividend yield. These factors collectively contribute to a low overall stock score, highlighting considerable risk.
To see Spark’s full report on CCM stock, click here.
More about Concord Medical Services
Concord Medical Services Holdings Limited operates in the healthcare industry, focusing on providing medical services and healthcare management. The company is involved in the operation of a network of radiotherapy and diagnostic imaging centers in China, and it also has a subsidiary, Concord Healthcare Group Co., Ltd., listed on the Hong Kong Stock Exchange.
Average Trading Volume: 33,537
Technical Sentiment Signal: Strong Sell
Current Market Cap: $25.36M
Find detailed analytics on CCM stock on TipRanks’ Stock Analysis page.